Abstracts

278 – Perturbations in the Myeloid Cell Compartment Persist in Early-Treated People Living With HIV

Background Despite antiretroviral therapy (ART) initiation during acute HIV infection (AHI), persistent immune alterations remain. To better understand the deviation from immune homeostasis, we performed longitudinal phenotypic and transcriptional profiling of peripheral blood mononuclear cells (PBMCs) from early-treated people living with HIV (PLWH) using HIV uninfected controls as reference population. Methods Matched PBMC samples were…

560 – Prevalence of InSTI Drug Resistance: Population-Based Data From 4 African Countries, 2019-2022

Background With excellent tolerability, effectiveness and high barrier to drug resistance, integrase strand transfer inhibitors (INSTI) are widely used in HIV treatment. We examined population-based INSTI DR mutation (DRM) prevalence in four high HIV burden African countries using INSTI as first-line antiretroviral (ARV) therapy. Methods We pooled and analyzed data from Population-based HIV Impact Assessments…

833 – Sex Matters: A Bayesian Approach to Analyzing Sex Differences in an African Pediatric Cohort

Background Females often present with lower plasma viral loads and higher CD4 counts early in infection yet may experience greater HIV-related morbidity and mortality. In contrast, evidence among infants living with HIV (ILHIV) remains limited and sometimes conflicting, particularly regarding viral dynamics, immune reconstitution, and reservoir size. This gap hampers understanding of sex-related differences in…

860 – Global Cohort Analysis of Dolutegravir Viral Response in Children and Adolescents Living With HIV

Background We describe virological outcomes in a large multiregional cohort of children and adolescents living with HIV (CALHIV), aged 0-19 years, receiving dolutegravir (DTG)-based ART in low- and middle-income countries.  Methods We included all CALHIV initiating or transitioning to DTG-based ART since 2018, to 2024 in clinics across West, East, Central and Southern Africa, the…

1073 – California Legislation Allowing Pharmacist Dispensation of PrEP Increased Pharmacist Prescribing

Background California (CA) State Bill 159 (SB159), enacted in October 2019, aimed to expand PrEP access and reduce HIV incidence by broadening authority for pharmacists to prescribe PrEP without physician approval and prohibiting insurance preauthorization requirements.  This study examined SB159’s impact on pharmacist PrEP prescribing, changes in number of PrEP prescriptions filled, and the relation between…

354 – HIV DNA and RNA Levels Before and After ART in Natural Controllers and Comparison to Noncontrollers

Background In ART-suppressed PWH, HIV transcription is variably blocked at the stages of elongation, completion, and splicing. Few studies have measured CA-HIV RNA in elite controllers (EC), and these have been limited to detection of unspliced HIV RNA.  We hypothesized that EC would differ from ART-suppressed noncontrollers (NC) in the blocks to various stages of…

647 – Gut Microbiota, Circulating Inflammation Markers, and Cardiac Dysfunction in Women and Men With HIV

Background Alterations in the gut microbiota have been implicated in both HIV infection and cardiovascular disease(CVD). How microbial alterations relate to host immunity and inflammation, and their relationships with cardiac dysfunction, remains largely unknown, especially in the context of HIV. Methods We examined associations of gut microbial features(fecal 16S rRNA sequencing) with cardiac dysfunction(left ventricular…

941 – Comparing Behavioral and Socio-Structural Exposures for Women’s HIV Prevention in the Urban South

Background Cisgender women, particularly Black women in the Southeastern U.S., experience substantial HIV risk. While current prevention strategies emphasize behavioral risk, understanding the relative contributions of socio-structural factors in comparison is essential for informing risk assessment and guiding equitable interventions. This study aimed to evaluate the effects of socio-structural and behavioral exposures on HIV risk among…

821 – Timing of Dolutegravir Initiation and Birth Outcomes Among Pregnant Women Living With HIV in Kenya

Background The effect of antiretroviral therapy (ART) initiation before conception and at different stages of gestation on adverse perinatal outcomes remains uncertain, as existing studies yield conflicting results. Few studies evaluate how the timing of dolutegravir (DTG)-based ART initiation during pregnancy affects perinatal outcomes. Methods We analyzed data from pregnant women living with HIV (WLHIV)…